Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Penny Abernethy at p.abernethy@oxfordglobal.co.uk

Confirmed speakers for 2013

  • Nataliya Afonina
    Director clinical release & stability testing, BMS
  • Debra Brennan
    Senior Scientist, Boehringer-Ingelheim
  • Katharine Cain
    Senior Scientist, UCB
  • Ho Cho
    CTO, Ambrx
  • Ciaran Cronin
    Head, parallel protein production, Pfizer
  • Jérôme Célérier
    Senior Scientist, Sisene
  • Gerhardus de Jong
    Ultrecht University Professor, Biomolecular Analysis
  • Michael Doyle
    Senior Principal Scientist and Group Leader, Bristol-Myers Squibb
  • James Errey
    Associate Director Protein Biochemsitry, Heptares
  • Markus Eser
    Head of Protein Chemistry, Affimed
  • Brian Fennell
    Principal Scientist Global Biotherapeutics Technologies, Pfizer
  • Bernd Gerhartz
    Director Head of Protein Science Group, Novartis
  • Tariq Ghayur
    Senior Research Fellow, Abbott
  • Boris Gorovits
    Director, Pfizer
  • Maria Groves
    Senior Scientist, Lead Generation, ADPE, MedImmune
  • Steffen Hartmann
    Global Head Protein Developability, Integrated Biologics Profiling, Novartis
  • Sandro Keller
    Professor, Molecular Biophysics Group, University of Kaiserslautern
  • Alastair Lawson
    VP Structural Biology, UCB
  • Alexey Lugovskoy
    Senior Director of Therapeutic Design, Merrimack
  • Lorenz Mayr

    Executive Director, AstraZeneca

  • Andreas Menrad
    CSO, Ablynx
  • Dario Neri
    Professor, ETH Zurich
  • Karyn O'Neils
    CSO, Centyrex
  • Joel Richard
    VP, Ipsen
  • Andrew Sanderson
    Principal Scientist, GSK
  • David Satijn
    Associate Director Antibody Science, Genmab
  • Ralf Schumacher
    VP & Head of Large Moleculte Research, Roche
  • Manfred Schuster
    COO, Apeiron Biologics
  • Arne Skerra
    Professor TU Munchen, Founder & CEO, XL-protein
  • Stefan Stahl
    Professor, Dean, School of Biotechnology, KTH – Royal Institute of Technology
  • Albert Stewart
    Director Structural Biology, Pfizer
  • Ali Tehrani
    CEO, Zymeworks
  • Bernhardt Trout
    Professor Of Chemical Engineering, MIT
  • Alex Weidenmann
    Project Manager Multispecifics, Pieris AG
  • Trevor Wilkinson
    Associate Director, Protein Sciences, Lead Generation, Department of Antibody Discovery and Protein Engineering, MedImmune
  • William Winston
    Head Antibody Engineering, Aveo Oncology
  • Ulrich Wuellner
    Senior Scientist, Covagen
testimonials_3testimonials_1testimonials_6testimonials_7testimonials_4testimonials_5testimonials_2